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Medicine has long been looking at nanotechnology to continue its development in new directions, 
especially towards personalized therapy and early diagnosis of some fatal diseases. Amongst the many 
facets of the so-called “nanomedicine”, those related to the application of magnetic forces are particularly 
appealing to detect, or even to guide, nanodevices in a minimally-invasive manner. This special issue covers 
only the most recent advances in “magnetic nanomedicine”. The aim is to provide the medicinal chemist 
with a concise guide of both 1) the most innovative tools that offer new paradigms for clinical intervention, 
and 2) the more conventional approaches that made significant progress to realise the ambitious goal of 
reaching the patient.  
Tay and Di Carlo open this hot topic discussing the innovative use of magnetic nanoparticles to generate 
mechanical forces and allow remote control of brain circuits. This new paradigm is discussed in the wider 
context of promising techniques for the minimally-invasive manipulation of cell behavior with high 
spatiotemporal resolution. Comparison with more conventional (electrical stimulation and drugs) and 
second generation (ultrasound and light) techniques is made, to highlight requisites, strengths and 
weaknesses of each approach. The authors conclude with a view of the challenges and progress in related 
fields to translate the use of such novel nanoparticle-based platforms, both in research and clinical 
settings.  
Magnetic drug targeting using nanocarriers based on superparamagnetic iron oxide nanocrystals (SPIONs) is 
another interesting approach in magnetic nanomedicine that is discussed by Kralj and co-authors, including 
myself. Magnetic nanocarriers based on SPIONs have emerged amongst other nanostructured materials in 
medicine, thanks to their excellent biocompatibility. In fact, research in this area reached a level of maturity 
to the point that several products are already in the market both for research and clinical use. A snapshot 
of the current situation is presented, as well as a discussion on current and future strategies for the design 
and fabrication of magnetically responsive nanocarriers based on SPIONs, including the underlying physical 
requirements, the possibility of drug loading, and the control of drug release at the targeted site.  
Iron-based nanostructured components find application in the well-established field of Magnetic 
Resonance Imaging (MRI). In particular, bimetallic particles that also contain gold have been attracting 
increasing interest for biomedical use because of the synergy with the plasmonic features and 
biocompatibility of the inert gold component. These hybrid nanomaterials are suitable not only for imaging, 
but also for therapeutic and analytical applications. They are described in the minireview by Sanavio and 
Stellacci. Another approach to advance the current status of MRI agents is the use of innovative 
nanostructured carriers for improved relaxivity and resolution, increased circulation time, stability and 
better targeting. An interesting option in this sense is provided by cubosomes, which are described by 
Alcaraz and Boyd. These self-assembled nanostructures are analogous to liposomes. However, they contain 
a complex internal structure of high-surface area that is responsible for attractive properties. The 
minireview included in this hot topic provides a brief overview of what cubosomes are, how they are 
prepared and characterised, their use in MRI, and it also includes a discussion on future developments in 
the field.  
Besides MRI, there are also other diagnostic applications for magnetically-responsive materials, where 
magnetic forces can be used for purification and enrichment purposes. In modern society, where the fight 
against cancer still presents a number of challenges, there is an active quest towards the identification and 
detection of useful biomarkers. The manuscript by Piovesana and Capriotti ilustrates the use of novel 
magnetic nanostructured materials for  
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the diagnosis of peptide and protein biomarkers. Their concise review deals with the key aspects, such as 
performance comparison over conventional techniques, ease of use, derivatization versatility and 
automation, together with quantification through coupling with powerful characterization techniques, such 
as mass spectrometry.  
One of the current limitations to exploit magnetic nanomedicine to its full potential is given by the need to 
extend current knowledge about the physical challenges in the translation of magnetic forces in a biological 
context in vivo. A useful view of the existing models available to medicinal chemists, their prospects and 
limitations, is provided by Prof. Winkler. Good computational models could accelerate the design of 
magnetic nanoparticles for medical applications, including: hyperthermia induction in aberrant cells for 
cancer therapy, medical imaging, targeted drug delivery, or gene therapy.   
Key technological advancements require not only better models, but also innovative components, and the 
contribution by Prof. Prato et al. discusses how 2D-graphene and its related materials allow for a qualitative 
leap in the performance of magnetic nanodevices used in medicine, spanning from MRI and controlled drug 
delivery, to magnetic photothermal therapy and cellular separation and isolation. The authors include a 
concise view on the chemical approaches used in the preparation of magnetic hybrids that contain 
graphene-based materials and conclude their interesting contribution by highlighting on the use of these 
magnetic hybrids towards the next generation of theranostics. This work is followed by Dr. Parry’s mini-
review on the use of another innovative nanostructured component for novel medical devices, i.e., 
nanocellulose. Nanocellulose is an attractive material for wound dressings, medical implants, drug delivery, 
tissue engineering, and diagnostics. Key advantages include low-cost, biocompatibility, and 
biodegradability. Importantly, nanocellulose displays functional groups, which can act as chemical handles 
to introduce further properties. In addition, composites can be envisaged also for innovative biomedical 
use such as magnetically-responsive nanomaterials and 3D printing.   In conclusion, this hot topic issue of 
Current Medicinal Chemistry aims at introducing key areas of magnetic nanomedicine to assist the 
medicinal chemists who wish to embrace novel research directions and who seek to understand the key 
relevant principles and current challenges with up-to-date information and forward-looking perspectives. 
The applications in medicine illustrated here take advantage from the high potential of emerging 
nanotechnologies and nanostructured materials. In particular, concepts of medicine innovation are 
described, which draw strength from the combination of nanotechnologies and nanomaterials with 
convenient magnetic forces, to realise futuristic smart devices for better therapy and diagnosis.  
  
  
  
 
